The Sick Times: A journalist-founded website chronicling the Long Covid crisis

SNT Gatchaman

SNT Gatchaman

Senior Member (Voting Rights)
Staff member
https://thesicktimes.org/

We report on the common, life-changing disease following Covid-19 infection that affects over 65 million people worldwide and can be fatal. Our coverage spans related infection-associated chronic conditions such as myalgic encephalomyelitis, dysautonomia, mast cell activation syndrome, and more. Unlike many outlets, we continue to report on the impact of the ongoing Covid-19 pandemic. No denial, minimizing, or gaslighting here.

Join us as we investigate injustices, challenge powerful institutions, wield through the latest research, assess Covid-19 data, and offer a platform for those most affected by the crisis.

Betsy Ladyzhets and Miles Griffis
 
Last edited:
Since our initial call, Betsy and I have spent the past few months speaking with advisors including pwLC, pwME, physicians, researchers, and public health experts, as well as journalists like Ed Yong, Julie Rehmeyer, David Tuller, and Sean Strubb, the founder of POZ magazine. The Sick Times will be a high-impact publication that covers the latest research, holds powerful actors accountable, performs deep-dive investigations, and offers a platform for pwLC, researchers, caretakers, physicians, and others to share their ideas and opinions on the Long Covid crisis.
Click to expand...
 
Thanks SNT, it looks useful. There's a reader's survey asking for ideas for stories and resources.

I mentioned the Cochrane issue (and the petition), as well as the trend for ME/CFS to be disappeared, replaced with diagnoses of Long Covid and psychosomatic Functional Disorders. And this forum.
 
Copied post

David M Tuller The Launch of The Sick Times, a new online publication

Presentation:
In mid-November, Betsy Ladyzhets and Miles Griffis, two smart, young journalists, announced the launch of The Sick Times (https://thesicktimes.org/), an online publication focused on long Covid and related syndromes, including ME/CFS. I have met both of them in the last couple of years and have been impressed with work covering the pandemic, so I’m really looking forward to seeing how The Sick Times evolves. (I interviewed Ladyzhets earlier this year about her investigation of the U.S. National Institutes of Health’s RECOVER program for long Covid, which was published by STAT.) I talked with Ladyzhets and Griffis the other day about why they started The Sick Times, their plans for the publication, and related issues.


Click to expand...
 
Last edited by a moderator:
The Sick times is hiring two part time writers, and accepting pitches for Commentary/analysis pieces on Long Covid. 400-1200$ is paid per piece.

I personally don’t have enough energy to contribute, but for some people here (a lot of you are really smart and have some interesting ideas to share), this could be a great opportunity.

See: https://thesicktimes.org/write-for-us-part-time-opportunities/
 
Last edited:
Now with a podcast as well called "Still here":

In the pilot episode of Still Here: A Podcast From The Sick Times, co-hosts Miles Griffis and Betsy Ladyzhets talk with podcast producer James Salanga about the latest COVID-19 numbers. Engagement editor Heather Hogan joins James, Miles, and Betsy to recap the NIH RECOVER-TLC meeting from last week. And in research, a hopeful update about a nasal spray effective at blocking respiratory viruses — including COVID-19.

https://thesicktimes.org/2024/10/04/still-here-10-4-2024-links-and-transcript/
 
The latest podcast episode celebrates their one year anniversary:

The Sick Times - Still Here, November 15: Links and transcript

https://thesicktimes.org/2024/11/15/still-here-november-15-links-and-transcript/
The Sick Times said:
Summary

This week, we celebrate one year of The Sick Times! The Sick Times team discusses the newsroom’s origin story, what the publication means to them, and what the next year (and hopefully years, plural) holds.

Also in this episode: the latest COVID-19 numbers, and recapping the team’s coverage of the Fall 2024 PolyBio Symposium on Long COVID Research.
Click to expand...
 
You must log in or register to reply here.
Back
Top Bottom